FDA.reportPublic FDA data

trastuzumab-strf 420 MG per 20 ML Injectable Solution

RxCUI
2700727
RxNorm name
trastuzumab-strf 420 MG per 20 ML Injectable Solution
Display name
trastuzumab-strf 420 MG per 20 ML Injectable Solution
Full name
trastuzumab-strf 420 MG per 20 ML Injectable Solution
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:51

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761346Hercessitrastuzumab-strf351(k) BiosimilarRx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
285d2142-5bfa-401c-9246-7de21c4451aftrastuzumab-strf 420 MG per 20 ML Injectable SolutionSY4These highlights do not include all the information needed to use HERCESSI safely and effectively. See full prescribing information for HERCESSI. HERCESSI TM (trastuzumab-strf) for injection, for intravenous use Initial U.S. Approval: 2024 HERCESSI (trastuzumab-strf) is biosimilar* to HERCEPTIN (trastuzumab).20250321
285d2142-5bfa-401c-9246-7de21c4451aftrastuzumab-strf 21 MG/ML Injectable SolutionSCD4These highlights do not include all the information needed to use HERCESSI safely and effectively. See full prescribing information for HERCESSI. HERCESSI TM (trastuzumab-strf) for injection, for intravenous use Initial U.S. Approval: 2024 HERCESSI (trastuzumab-strf) is biosimilar* to HERCEPTIN (trastuzumab).20250321
285d2142-5bfa-401c-9246-7de21c4451aftrastuzumab-strf 420 MG in 20 ML Injectable SolutionPSN4These highlights do not include all the information needed to use HERCESSI safely and effectively. See full prescribing information for HERCESSI. HERCESSI TM (trastuzumab-strf) for injection, for intravenous use Initial U.S. Approval: 2024 HERCESSI (trastuzumab-strf) is biosimilar* to HERCEPTIN (trastuzumab).20250321